-
Sandoz Canada receives Health Canada approval for Erelzi (etanercept) in the Treatment of Psoriatic Arthritis (PsA) in Adult Patients
firstwordpharma
January 22, 2019
Erelzi is the only etanercept biosimilar to be indicated for reducing the signs and symptoms of psoriatic arthritis (PsA) in adult patients.
-
Roquette & Thermo Fisher Enter Distribution Deal
contractpharma
December 21, 2018
Roquette and Thermo Fisher Scientific have entered a distribution rights agreement for the Roquette portfolio of pharmaceutical ingredients in the United States and Canada to support the high growth potential in these markets.
-
Health Canada warning: Health products by Botanicals Inc. may be harmful
biospectrumasia
December 17, 2018
Health Canada has seized all of the products, prescription drug ingredients and manufacturing equipment found at the site, and suspended the 11 natural health product licences held by the company
-
Mundipharma to launch Cold Defence in Turkey and Canada
biospectrumasia
August 28, 2018
Cold Defence™ is a natural product with anti-viral effects that helps to eliminate 99% of cold and flu viruses and shorten the duration of common colds
-
Pharmascience Launches (Pr)pms-TRANDOLAPRIL
americanpharmaceuticalreview
July 11, 2018
Pharmascience has launched in Canada Prpms-TRANDOLAPRIL (angiotensin-converting enzyme inhibitor), indicated for the treatment of mild to moderate essential hypertension and the treatment following acute myocardial infarction.
-
Avara Pharmaceutical to buy Novartis’s production plant in Canada
pharmaceutical-technology
June 01, 2018
US-based Avara Pharmaceutical Services has signed an asset purchase agreement to acquire Novartis Technical Operations’ sterile manufacturing facility for injectable medicines in Quebec, Canada.
-
Doctors in US and Canada launch sweeping pharmaceutical reform proposal
worldpharmanews
May 23, 2018
The skyrocketing cost of prescription drugs is one of the biggest concerns for American voters. However, in his proposal last Friday,
-
Canada announces $7.9 M investment for health innovations in India
biospectrumasia
February 27, 2018
Three of the projects will empower vulnerable, low-income women and girls in rural villages in India.
-
Abbott’s new technology obtains Health Canada license
biospectrumasia
July 04, 2017
With every scan, the system provides real-time glucose results, glucose direction, and eight-hour historical trend. The reader retains data for approximately 90 days.
-
Recordati Launches Recordati Rare Diseases Canada, Inc.
americanpharmaceuticalreview
April 14, 2017
Biopharmaceutical company, Recordati, has announced the incorporation of its Canadian affiliate, Recordati Rare Diseases Canada Inc.